Characteristics of studies of ANA, SMA and SLA/LP.

*/#/&: cut-off and assays for ANA/SMA/SLA. 1/2: mean/median age of AIH patients. §/¶: median age of AIH-1/2.
IIF = indirect immunofluorescence, ELISA = enzyme-linked immunosorbent assay, RLA = radioligand assay. ANA = antinuclear antibodies, SMA = anti smooth muscle antibodies, SLA/LP = antibodies to a soluble liver antigen/liver pancreas, AIH = autoimmune hepatitis, PBC = primary biliary cirrhosis, AIC = autoimmune cholangitis/cholangiopathy, CVH = chronic viral hepatitis B or C, SLE = systemic lupus erythematosus, MCTD = mixed connective tissue disease, HC = healthy controls, LDC = liver disease controls, CD = coeliac disease, PSC = primary sclerosing cholangitis, NBNC = chronic hepatitis-non-B, non-C, DILI = drug-induced liver injury, NASH = non-alcoholic steatohepatitis, UC = ulcerative colitis, NAFLD = non-alcoholic fatty liver disease, CTD = collagen diseases.